Summary: X-chromosome is often excluded from whole-genome association studies due to a number of complexities.
Introduction
In genome-wide association studies (GWAS) and next generation sequencing (NGS) studies, X-chromosome has been often excluded due to its complexity compared to autosomes. Wise et al. (2013) found that for every GWAS paper published from January 2010 to December 2011 and included in the NHGRI GWAS catalog, "only 33% (242 out of 743 papers) reported including the X-chromosome in analyses". There are many analytical challenges related to X-inclusive association studies. Some are for both autosomes and X-chromosomes, and some are specific to X-chromosomes.
Throughout this paper, we use Y to denote phenotype or outcome of interest, which could be binary or continuous, and G to denote genotype of a single nucleotide polymorphism (SNP). A single SNP has two alleles: r and R, one of which is the risk allele with allele frequency p and the other is reference allele. It needs to be noted that the major allele could be risk allele and p is not necessarily the minor allele frequency (MAF) less than 0.5. An autosome SNP has three genotypes, namely rr, rR and RR. Coding of G for each genotype could be G A = (0, 1, 2) for additive effect, and G D = (0, 1, 0) for dominant effect. An Xchromosome SNP has five genotypes, rr, rR and RR for females and r and R for males.
We will discuss the coding of G in more details below. The main question of phenotypegenotype association analysis is to test H 0 : Y is not associated with G. In addition, we use S to represent sex-specific effect and Es to represent other environmental effects. When both effects exist, there may also exist G×S: genotype-sex interaction, G×E: gene-environmental interaction and S × E: sex-environmental interaction. β (with corresponding subscripts) denotes the effect sizes of each covariate.
For any statistical approaches focusing on X-chromosome analysis, we summarize 8 major challenges that must be properly addressed. As we discuss below, challenges C1 to C3 are genome-wide, and C4 to C8 are specific to X-chromosome.
• C1: Quantitative vs. binary traits/phenotypes
• C2: Genotype based vs. allele based
• C3: Additive vs. genotypic model (with dominant term)
• C4: Sex S as a covariate must be included or not
• C5: Genotype-sex interaction G × S should be included or not
• C6: X-chromosome inactivation (XCI) vs no inactivation
• C7: If XCI, the inactivation is random vs. skewed
• C8: Reference allele R vs. r C1 and C2. Classic allele based tests from case-control studies require binary phenotype data so that the Pearson chi-squared test statistics can be computed by contingency tables.
HardyWeinberg equilibrium (HWE) assumption must also be met to achieve correct type I errors. For quantitative phenotypes and any departure from HWE, the most commonly used approaches are genotype based tests under regression models. Regression models support various types of phenotype data and HWE assumption is not required. Sasieni (1997) had a detailed discussion about allele based tests with HWE assumption versus genotype based tests. Another reason in favor of regression model is that additional covariates such as environmental factors can be easily incorporated in the model.
C3.
The genotype-based tests require a correct assumption of the genetic model, which has been a long standing controversy. For both autosome and X-chromosome SNPs, the genetic model either assumes a specific relationship between the effects of rr, rR and RR, such as recessive, additive, dominant, multiplicative, or assumes no specific relationship between each genotype (genotypic model), where the total genetic effects are decomposed as a combination of additive and dominant effect. Each assumption leads to a different model, and Bagos (2013) had a good review paper of several model selection approaches. When the true genetic model is unknown, the main idea is to combine each test statistic or p-value under different models. However, the way to combine these tests are quite ad hoc, and it is lack of theoretical justifications that how and why they should be combined.
On the other hand, a common practice for simplicity is to only examine additive models, as the additive model has reasonable power to detect both the additive and dominant effects (Bush and Moore, 2012) . In addition, Hill et al. (2008) have shown that additive variance typically accounts for over half and often close to 100% of total genetic variance, even if there are non-additive effects at the level of gene action. It needs to be noted that people are usually reluctant to assume the genotypic model. Although it is the most general assumption, the test is believed to be less powerful due to the extra degree of freedoms of the test statistics.
However, we find such belief is not necessary correct in the context of GWAS. We derive the upper bound of the power loss by incorporating the other covariate for dominant effect and compare to the potential power gain, and find it may be worth to allow both the additive and dominant effects in the model. C4 and C5. The other challenges are specific to X-chromosome, due to the fundamental differences between females and males. First, sex-specific effects may exist in biological point of view. Next, sex is a classic confounder associated to both the genotype and the phenotype.
If covariate S is not included in the model, the type I error for testing the genotype effect can be inflated. Ozbek et al. (2018) has extensitve simulation studies to show the type I error inflation. Furthermore, different effect sizes of the same SNP in females and males are recognized as genotype-sex interaction effects. Proper tests allowing for interaction effects need to be developed.
C6 and C7. The next complications relate to the uncertainty of the biological status of Xchromosome SNPs. X-chromosome inactivation is the phenomenon that one of the two alleles in females is selected to be silenced, so that the effects of female genotypes may be reduced.
In brief, the additive coding of rr, rR and RR becomes 0, 0.5 and 1 rather than 0, 1 and 2.
The challenge is that although we know about 15% of genes on X-chromosome are escaped from XCI at population level (Carrel and Willard, 2005) , we are uncertain if XCI occurs or escapes on each SNP. Even though we are certain that XCI occurs on one particular SNP, at individual level it is still unknown which allele is inactivated. Wang et al. (2014) discussed various studies suggesting a biological plausibility of skewed inactivation so that one allele is more likely to be inactivated than the other, while the additive model in essence assumes two alleles have equal probability of inactivation.
C8. Lastly, when allele frequency difference is significant, females and males may have different minor alleles. For autosome SNPs, people usually choose the minor allele with allele frequency less than 0.5 as the risk allele, because switching the risk allele and reference allele does not change the statistical inference and thus choosing an arbitrary risk allele does not cause a problem. However, for X-chromosome SNPs, switching the reference allele and risk allele may lead to different statistical models and yield different inferences. When minor allele is different for females and males, the risk allele may be unknown and it becomes a challenge to choose the risk allele. It needs to be noted that sex-stratified tests may not solve the challenge, because stratification by sex may result in considerable loss of power (Clayton, 2008) , especially when allele frequency difference is significant for females and males.
We summarize the genotype codings after considering all X-specific challenges in Table 1 .
If the risk allele and XCI status are both unknown, there are 2 × 2 = 4 ways to code the additive covariates G A , and 2 ways to code the genotype-sex interaction GS. We will discuss in section 3 that skewed inactivation can be represented by the dominant effect coding G D .
[ In recent years, quite a few methods have been proposed for X-chromosome association studies. Zheng et al. (2007) proposed a few tests without considering X-chromosome inactivation. In contrast, Clayton (2008 Clayton ( , 2009 ) discussed analytical strategies assuming X-chromosome is always inactivated. Hickey and Bahlo (2011) and Loley et al. (2011) separately performed simulation studies and gave a thorough comparison of Zheng et al. and Clayton's tests. Based on these simulation studies, Konig et al. (2014) provided a detailed guideline for including X-chromosome in GWAS. The problem is they suggested different tests under different assumptions of genetic model, interaction effects, XCI status and so on, and it is not always possible to check these assumptions in practice. Gao et al. (2015) developed a software toolset for X-chromosome association studies. Recently, Zhongxue et al. (2017) improved existing sex-stratified tests by eliminating assumptions of genetic models, but they still needed to assume same risk allele for females and males, and sex-genotype interaction effects could not be measured. Focusing on XCI status, Wang et al. (2014) proposed a maximum likelihood solution to handle the uncertainty of XCI as well as skewed inactivation, and provided an XCI model selection method in their most recent paper (Wang et al., 2017 ).
In addition, Chen et al. (2017) used Bayesian model averaging (BMA) method to solve XCI uncertainty. However, both approaches only considered the additive model, and it is unclear how to include non-additive covariates in regression analysis with unknown XCI status.
Furthermore, both approaches were only illustrated by simulation studies, and it would be more appealing to derive a theoretical justification.
After reviewing all up-to-date methodology developments on X-chromosome association studies, we believe there is currently no approach which can handle all the 8 challenges discussed above simultaneously. The target of this paper is to propose a theoretically justified robust method that can solve all these challenges in most general framework, while the test powers are well maintained and even improved in most practical situations. The proposed tests are based on regression models, which allow for both quantitative and binary phenotypes as the response variables, departure from HWE and incorporating extra covariates. In section 2, we discuss the long-lasting controversy between additive models and genotypic models.
We revisit autosome SNPs for better illustrating of the benefits of genotypic model, which leads to a robust and sometimes much more powerful test than additive model. In section 3, we propose our main theory to address the challenges specific to X-chromosome. Section ?? provides supporting evidence to our proposed approach from application studies. Finally, we discuss the limitations of our approach and possible future work in section 4.
Additive vs. genotypic models

Theory of chi-squared distributions
For completeness and a more clear demonstration of the model selection challenge, we first revisit autosome studies. We find that in general, Hill et al. (2008) 
and the genotypic model is defined by
Although the HWE assumption is not required, we adopt it only for the purpose of simplifying the computation. The three genotype groups, rr, rR and RR have frequencies (1 − p) 
The power difference of W 1 and W 2 depends on both the non-centrality parameters and type I error α. When ncp 1 = ncp 2 = 0 or α = 0, both tests have no power; when non-centrality parameters are sufficiently large or α close to 1, both powers are close to 1. To achieve the maximum power loss of W 2 , we expect a moderate value of both the non-centrality parameter and α. We show the maximum power loss numerically in Web Appendix A, where the maximum power loss is 0.114 when α = 0.0025 and ncp = 10.6. It implies the power loss of using the genotypic model is capped by 0.114, regardless of type I error level, sample size and size of additive effects. It needs to be noted that although we assume additive model is correct, the maximum power loss is same for all 1 vs 2 degree of freedom models. For instance, if the dominant model is correct, the power loss is still capped by 0.114 by using the genotypic model. large as ncp 1 , the power gain can be much higher than power loss. Therefore, the genotypic model should not be overlooked in association studies with autosome SNPs.
Non-centrality parameters and corresponding test power computation
The above power computation is based on the theoretical values of non-centrality parameters, which must be computed from sample size and genotype effect size under the additive or genotypic model. When the sample size n → ∞, we want each test has a limiting chisquared distribution, but the non-centrality parameter under alternative hypothesis would move toward infinity for fixed value of β = (β 0 , β A , β D ). As in convention, we assume β = c/ √ n. Instead of specifying β, we fix the value of constant vector c, so that β → 0 and the non-centrality parameter under alternative hypothesis converges to finite number as n → ∞.
We provide more discussions about the convergence of asymptotic non-centrality parameters in section 4. We then use standard technique in Cox and Hinkley (1974) to compute the asymptotic non-centrality parameters for the test under genotypic model as described below.
We write the generalized linear models in matrix form: E[g(Y )] = Xβ where X is the design matrix. Suppose we want to test H 0 : β 2 = 0, where β 2 is a subset of β. To compute the non-centrality parameter, we partition X = (X 1 , X 2 ), β = (β 1 , β 2 ) according to the null hypothesis, and the expected Fisher information matrix of β is partitioned accordingly:
Then the non-centrality parameter equals to
For genotypic model, β 1 = β 0 , X 1 = 1 n , and [ Figure 1 about here.] Figure 1 indicates that the power gain by using the genotypic model can be as much as 0.4 in realistic situations, which is quite significant compared to the maximum power loss of 0.113. In practice, the strength of dominant effect is usually unknown. In such case including the dominant covariate is more like a risk-free solution: without sacrificing much test power, the potential power gain may be significant.
X-chromosome Challenges
Type I error control and choice of risk allele
We now consider association analysis on X-chromosome SNPs where the covariates are defined in Table 1 . When testing for the genotype effects, we note that they are usually correlated with sex effects. The correlation has two implications. First, when genotype effect exists, sex becomes a confounding variable. The sex effect is hard to explain separately and it in fact helps explaining the genotype effect. Second and more importantly, when sex effect exists but genotype effect does not exist, the correlation will lead to an inflated type I error for testing the genotype effect if sex is not included in the model. Including sex as the covariate warrants the correct type I error for testing the genotype effect. ? provided extensive simulation studies to show both the type I error inflation and correct type I error control when sex is included, and we would agree with their conclusion that sex should always been included in regression models.
As shown in Table 1 
where we want to test β 1A = 0 or β 2A = 0 under each model. We note that G A,r,N = 2 − G A,R,N − S, which yields β 1A = −β 2A , so it is equivalent to test β 1A = 0 and β 2A = 0 under two models, and we can further show that test statistics under two models are exactly equal. It provides us some intuition that the problem of unknown risk allele is solved when sex is included as the covariate because two tests then become indistinguishable. To make our intuition more rigorous, we propose the following theorem: 
Sex-genotype interaction and XCI uncertainty
For X-chromosome SNPs, genotype-sex interaction effect may exist, so that the unit effect of one copy of r or R may not be the same for males and females. The interaction is defined by GS = G A × S. It is straightforward to check GS has two different codings depending on the risk allele of males: GS R and GS r as defined in Table 1 .
We have explained when S is included in the model, two design matrices with different risk alleles become invertible linear transformations. Furthermore, when both S and GS are included, we can easily show all four design matrices of (1, S, G A , GS) with different risk alleles and XCI status are invertible linear transformations of each other, and for testing the null hypothesis H 0 : β A = β GS = 0, the design matrix of the covariates which are not being tested, i.e., (1, S), remains unchanged between different coding schemes of G A and GS. Figure 2 implies that in terms of testing, switching risk allele has no effect when sex is included, and the effect of inactivating X-chromosome alleles is indistinguishable to the effect of sex-genotype interaction. With S and GS included in the model, we do not need to know the risk allele and XCI status, and any one group of covariates of G A , GS and S simply yields the same test statistic. Therefore, we now recommend including both S and GS in regression models to override the uncertainty issues about risk allele and XCI:
Dominant effects and skewed XCI
The dominant effect G D defined in Table 1 is invariant to risk allele and XCI status.
Similar to autosome SNPs, the first reason to include the dominant effect is to capture any departure from the additive effect of the heterozygous genotype rR. For X-chromosome, another important reason is that the dominant effect may also characterize the skewness of XCI.
Skewed XCI is the effect that one allele is more likely to be inactivated than the other for female SNPs. For homozygous genotypes rr and RR, the genotype effects are always reduced to a half because both alleles have same effect and which allele is inactivated makes no difference. For heterozygous genotype rR, if one allele is more likely to be inactivated, at population level the effect of rR will move towards to the effect of either rr or RR. For example, we denote the effect of rr by 0 and effect of RR by 1. Then rR will have an effect of either 0 or 1 at individual level depending on the inactivated allele. If two alleles are equal likely to be inactivated, at population level we expect half of r and half of R are inactivated, so that the averaged group effect of rR is 1/2. If r is more likely to be inactivated, we expect more 1's than 0's on average, and rR has an average effect greater than 1/2. With skewed inactivation, the effect of rR ranges from 0 to 1, so that the skewness is equivalent to a dominant effect making the the effect of rR different from 1/2. In conclusion, including the covariates G D not only captures real dominant effect, but also represents any skewness of inactivation.
When XCI status is unknown, it is more likely that the amount of skewness of the inactivated SNP is also unknown. In such case we recommend including the dominant covariate G D to explain any possible skewness. Because the coding of G D is invariant to risk allele and XCI status, including G D in the model does not change the linear transformation relationships specified in Figure 2 . When different covariates are chosen, Table 2 summarizes for each model whether it has problem with inflated type I error and unknown risk allele (Challenge C4 and C8), sex-genotype interaction and XCI uncertainty (Challenge C5 and C6), and dominant effects and skewed XCI (Challenge C7). Other covariates representing environmental effects can be freely added to each model. The ultimate model we recommend
which resolves all X-chromosome specific challenges, as shown in Table 2 .
[ 
We use the same technique as described in section 2 to define β = (β 0 , β S , β A , β D , β GS ) = c/ √ n and fix the value of c so that the non-centrality parameter under alternative hypothesis converges to finite number as n → ∞. Then the non-centrality parameter for the tests under model M 4 can be similarly computed following Cox and Hinkley (1974) . 
Discussion
The assumption that β → 0 under alternative hypothesis may not be quite intuitive, but it seems to be a common assumption when studying the theoretical properties of chi-squared tests (Cox and Hinkley, 1974; Lagakos, 1992, 1993; Neuhaus, 1998) . Let β = (β 1 , β 2 ), where the null hypothesis is β 1 = 0 and β 2 is the nuisance parameter not being tested. Among the common practices, there is no doubt to adopt a sequence of alternative hypothesis of β 1 converging to 0, but it is not quite clear whether β 2 should also be assumed to converge to 0. In the context of GWAS, we believe it is most reasonable to assume β 1 and β 2 converge to 0 at similar rates, because both parameters denote the genotype effect of the same SNP, and there is no reason to believe the additive, dominant and interaction effects are on different scale for any sample size. Therefore, we assume both β 1 and β 2 converge to 0 as n → ∞ at the rate of 1/ √ n.
We have shown in X-chromosome association study, Sex should be included for correct type I error. For autosome study, sex is usually not included, but the result from X-chromosome suggests that when sex is a confounding variable, e.g., female and male allele frequencies unequal, it should also be included as a covariate for autosome analysis. If the risk allele is uncertain, we also recommend including sex to bypass the uncertainty.
When allele frequency difference is significant and females and males have different minor alleles, it may become unclear that if females and males have the same risk allele or each sex has its own risk allele. As the interaction effects being allowed in the models, we are essentially allowing for different risk alleles for females and males. Switching the risk allele for males is equivalent to adding an interaction effect. Following Theorem 1, it is also easy to check when GS is included, switching the risk allele only for males or females will not change the test statistic.
Although the full model on X-chromosome is robust to XCI uncertainty, it is not capable to determine whether XCI occurs or not. It is possible to detect XCI by biological experiments (Carrel and Willard, 2005) , but statistical tests for XCI status may also be desired.
For quantitative trait, Ma et al. (2015) proposed a variance-based test for detecting XCI.
However, we do not find any statistical approach to testing XCI for binary trait up to date. It is a more challenging problem, because the binary outcomes can only yield a point estimate 
